Copy Link Print Information

Naptumomab

Avis client

Based on 1 Customer Validation

Naptumomab is a fusion protein of a tumor-targeting superantigen (TTS). Naptumomab stimulates the immune system to recognize and kill tumor cells and can be used in the study of refractory solid tumors such as renal cell carcinoma.

Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.

  • Stockage:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Experimental Validation Results for Naptumomab
  • Experimental Validation Results for Naptumomab
  • Experimental Validation Results for Naptumomab
  • Naptumomab Chemical Structure
  • Experimental Validation Results for Naptumomab
  • Experimental Validation Results for Naptumomab
  • Experimental Validation Results for Naptumomab
  • Naptumomab Chemical Structure
    Naptumomab Chemical Structure
CAS No.: 1412892-09-1
Size
Prix
Stock
Quantité
Amount: USD 0.00
Please select quantity
or
or

* Veuillez sélectionner la quantité avant d'ajouter des articles.

To place orders, for customer services and technical support, please contact: MedChemExpress USA

Tel: 609-228-6898 E-mail: [email protected] [email protected]

Data Download

To place orders, for customer services and technical support, please contact:

609-228-6898
[email protected] [email protected]
Trouvez votre distributeur local Your local distributor: Hycultec GmbHHycultec
  • Activité biologique
  • Chemical Information
  • Pureté et documentation
  • Références
  • Help & FAQs
You May Still Need
Top Publications Citing

Use of MCE Products
Keywords
100 mg

Obtenir un devis En stock

Please select quantity
Amount: USD 0.00
Sign in to MedChemExpress Sign In
Enregistrer
Sign in to MedChemExpress
Enregistrer un nouveau compte

At least 6 characters

Personalize your experience, you are currently not signed in. For a better experience, please create an online profile, you can:

Obtain points redemption prizes
Check out faster
Add multiple shipping locations
View orders
Assay Types
  • 1/16

    Fab-G1-kappa

  • 1/16

    Immobilized Naptumomab can bind Human 5T4/TPBG Protein (His Tag). The EC50 for this effect is 0.704 ng/mL.

  • 1/16

    Flow Cytometry analysis of MCF-7 cells with Naptumomab (HY-P99035, red) . Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).

  • Naptumomab Chemical Structure
    1/16
  • Naptumomab
  • Immobilized Naptumomab can bind Human 5T4/TPBG Protein (His Tag). The EC50 for this effect is 0.704 ng/mL.
  • Flow Cytometry analysis of MCF-7 cells with Naptumomab (HY-P99035, red) . Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. Then cells were stained with the primary antibody at 1/200 dilution for an hour at 4℃. Goat Anti-Human IgG H&L (AF488) (HY-P83776) was used as the secondary antibody at 1/1,000 dilution for 30 minutes at 4℃. Human IgG1 kappa (HY-P99001, blue) was used as the isotype control, cells without incubation with primary antibody were used as the unlabeled control (black).
  • Fab-G1-kappa